Preclinical Imaging in BSL-3 and BSL-4 Environments: Imaging Pathophysiology of Highly Pathogenic Infectious Diseases
Structural and functional imaging are emerging as powerful tools for studying highly pathogenic infectious disease processes. Nuclear imaging modalities and sophisticated radiolabeled probes can be used to track physiological or biochemical processes associated with viral infection. Magnetic resonance imaging can provide anatomical images with exquisite soft tissue contrast, while magnetic resonance spectroscopy can measure the relative amounts of certain metabolites in a given tissue. However, conducting medical imaging studies in a high-containment laboratory requires advanced applications and modification not only of image acquisition and analysis processes but also of the imaging equipment. Processes such as ex vivo labeling of cells are hampered by the personal protective equipment required for the safety of laboratory personnel. Modification of medical imaging equipment can prevent contamination of the equipment. Regardless of the challenges involved, medical imaging could provide valuable information to researchers developing therapeutics against highly pathogenic infectious diseases.
KeywordsDementia Influenza Polysaccharide Radionuclide Creatine
The authors thank Fabian de Kok-Mercado for his contribution to this work. The content of this chapter does not necessarily reflect the views or policies of the US Department of Health and Human Services or of the institutions and companies affiliated with the authors. This work was supported by the Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases (NIAID), and Battelle Memorial Institute’s prime contract with NIAID (HHSN272200200016I).
- Cherry SR, Sorenson JA, Phelps ME (2003) The gamma camera: performance characteristics. In: Physics in nuclear medicine. Saunders, Philadephia, PAGoogle Scholar
- Dannels WR et al (2008) Integrated system of MRI RF loop coils plus spacing fixtures with biocontainment tubes. WIPO Patent Application. PCT/US2008 073512, filed June 19, 2008Google Scholar
- de Kok-Mercado F, Kutlak F, Jahrling PB (2011) The NIAID integrated research facility at Fort Detrick. Appl Biosafety 16(2):58–66Google Scholar
- Dyall J et al (2012) Assessment of longitudinal changes in 18FDG uptake in bone marrow and lymph node and in lymph node volume in nonhuman primate model of monkeypox infection. World Molecular Imaging Congress Dublin, Ireland, Sep 5–8 2012Google Scholar
- Jain NK et al (2010) Biosafety level (BSL)-3 life support cell for studying live animals. Patent Application. PCT/US20100313821, filed June 16, 2010Google Scholar
- Kumar V (2005) Radiolabeled white blood cells and direct targeting of micro-organisms for infection imaging. Q J Nucl Med 49(4):325–338Google Scholar
- Leyson C et al (2012) Performance comparison of ultra-ultra high resolution collimators to low-energy high resolution collimators. J Nucl Med 53(suppl 1):2409Google Scholar
- US Department of Agriculture (2005) Agriculture bioterrorism protection act of 2002; possession, use and transfer of select agents and toxins, final rule. Fed Regist 70(52):13294Google Scholar
- US Department of Health and Human Services, Centers for Disease Control and Prevention, National Institutes of Health (2009) In: Chosewood LC, Wilson DE (eds) Biosafety in microbiological and biomedical laboratories, 5th edn. US Government Printing Office: Washington, DC. http://www.cdc.gov/biosafety/publications/bmbl5/. Accessed 5 Dec 2012
- US Food and Drug Administration (2002) New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Fed Regist 67(105):37988–37998Google Scholar